2022 Scientific Retreat- Session 8

Session 8: Investigating the Path from PI3K to Protein Synthesis to Tailor Prostate Cancer Therapy 
29th Annual PCF Scientific Retreat: October 28, 2022 | 5:00 PM – 6:00 PM 

Moderator: Daniela Brina, PhD 
Institute of Oncology Research, Switzerland 

Therapeutic Targeting of the Translational Machinery Blocks MDSCs and Enhances Anti-Tumor Immunity in Prostate Cancer 
Daniela Brina, PhD 
Institute of Oncology Research, Switzerland 

Defining the Therapeutic Selective Dependencies for Distinct Subtypes of PI3K Pathway-Altered Prostate Cancers 
Brett Carver, MD 
Memorial Sloan Kettering Cancer Center 

The Androgen Receptor Regulates a Druggable Translational Regulon in Advanced Prostate Cancer 
Andrew Hsieh, MD 
Fred Hutchison Cancer Center